Skip to main content

Table 6 Post-surgical complications

From: Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study

 

Current standard of care (N = 50)

Strict glucose control (N = 50)

P-Value

Survival Outcomes

 Graft Loss

11 (22.0)

16 (32.0)

0.260

 Death

9 (18.0)

12 (24.0)

0.461

Overall Survival

 30 Day Survival

49 (98.0)

49 (98.0)

0.999

 1 Year Survival

44 (88.0)

44 (88.0)

0.999

 3 Year Survival

43 (86.0)

42 (84.0)

0.779

 5 Year Survival

41 (82.0)

39 (78.0)

0.617

Graft Survival

 30 Day Graft Survival

48 (96.0)

49 (98.0)

0.999

 1 Year Graft Survival

44 (88.0)

42 (84.0)

0.564

 3 Years Graft Survival

41 (82.0)

38 (76.0)

0.461

 5 Years Graft Survival

39 (78.0)

35 (70.0)

0.362

Complications

 Bile Leak

15 (30.0)

14 (28.0)

0.826

 Biliary Stricture

20 (40.0)

13 (26.0)

0.137

 CVA

1 (2.0)

0 (0.0)

0.999

 Hepatic Arterial Stricture

3 (6.0)

1 (2.0)

0.617

 Major Cardiac Event

5 (10.0)

4 (8.0)

0.999

 Portal Vein Thrombosis

3 (6.0)

3 (6.0)

0.999

 Re-operation: Bleeding

6 (12.0)

10 (20.0)

0.275

 Re-operation: Other

9 (18.0)

15 (30.0)

0.160

 Renal Failure - Dialysis

9 (18.0)

6 (12.0)

0.401

 Wound Dehiscence

5 (10.0)

12 (24.0)

0.062

Infections

 Bacterial

26 (52.0)

27 (54.0)

0.841

 Fungal

7 (14.0)

11 (22.0)

0.298

 Transplant Incision Wound

7 (14.0)

9 (18.0)

0.585

 Viral

6 (12.0)

4 (8.0)

0.505

Hospital Outcomes

 Length of Stay (days)

11.0 [8.0 to 19.0]

12.5 [8.0 to 19.0]

0.384

  1. Data are presented as frequency (%) or median [25th percentile to 75th percentile], as needed